Cargando…
Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial
Background: Terlipressin is the first-line pharmacological treatment for hepatorenal syndrome. When terlipressin is unavailable, midodrine/octreotide or norepinephrine, with albumin, represent the alternative treatments. The comparative efficacy of these alternative regimens remains unclear. Objecti...
Autores principales: | El-Desoki Mahmoud, Eman Ibrahim, Abdelaziz, Doaa H, Abd-Elsalam, Sherief, Mansour, Noha O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283260/ https://www.ncbi.nlm.nih.gov/pubmed/34276366 http://dx.doi.org/10.3389/fphar.2021.675948 |
Ejemplares similares
-
Noradrenalin Versus the Combination of Midodrine and Octreotide in Patients with Hepatorenal Syndrome: Randomized Clinical Trial
por: Tavakkoli, Hamid, et al.
Publicado: (2012) -
Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide
por: Patel, Sharad, et al.
Publicado: (2017) -
Systemic hemodynamic and renal effects of midodrine and octreotide in cirrhotic patients with ascites
por: Kalambokis, Georgios N., et al.
Publicado: (2011) -
Comparison of the effect of midodrine versus octreotide on hemodynamic status in cirrhotic patients with ascites
por: Minakari, Mohammad, et al.
Publicado: (2011) -
Midodrine efficacy
Publicado: (2021)